Consejo Superior de Investigaciones Cientificas-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Consejo Superior de Investigaciones Cientificas - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014183
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that provides research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management of infrastructures and large facilities, promotion of the culture of science, transfer of results to the business sector, contribution to creation of technologically-based companies, training of specialist staff and scientific representation of Spain at international level. Its scientific areas include humanities and social sciences, biology and biomedicine, natural resources, agricultural sciences, physical science and technologies, materials science and technology, food science and technology, and chemical science and technology. The institute also offers research training, post graduate courses, and predoctoral contracts. CSIC is headquartered in Madrid, Spain.

Consejo Superior de Investigaciones Cientificas – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Inmunotek Enters into Agreement with CIB-CSIC 10
Licensing Agreements 11
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
HIVACAT Enters into Licensing Agreement with CSIC 13
Janus Developments Enters Into Licensing Agreement With UAB And ICMAB 14
Consejo Superior de Investigaciones Cientificas – Key Competitors 15
Consejo Superior de Investigaciones Cientificas – Key Employees 16
Consejo Superior de Investigaciones Cientificas – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Jul 20, 2016: Opened up new channels for antibacterial therapies to combat respiratory infections 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Key Facts 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Consejo Superior de Investigaciones Cientificas, Deals By Therapy Area, 2011 to YTD 2017 8
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Inmunotek Enters into Agreement with CIB-CSIC 10
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
HIVACAT Enters into Licensing Agreement with CSIC 13
Janus Developments Enters Into Licensing Agreement With UAB And ICMAB 14
Consejo Superior de Investigaciones Cientificas, Key Competitors 15
Consejo Superior de Investigaciones Cientificas, Key Employees 16

★海外企業調査レポート[Consejo Superior de Investigaciones Cientificas-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qorvo Inc (QRVO):企業の財務・戦略的SWOT分析
    Qorvo Inc (QRVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Leukocare AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • Alternatifbank A.S.:企業の戦略・SWOT・財務分析
    Alternatifbank A.S. - Strategy, SWOT and Corporate Finance Report Summary Alternatifbank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bank of China Ltd:戦略・SWOT・企業財務分析
    Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Biomm SA (BIOM3):製薬・医療:M&Aディール及び事業提携情報
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …
  • Samsung Electronics Co Ltd (005930):電力:M&Aディール及び事業提携情報
    Summary Samsung Electronics Co Ltd (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, printer, …
  • The Bank of Okinawa, Ltd. (8397):企業の財務・戦略的SWOT分析
    The Bank of Okinawa, Ltd. (8397) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Service Corporation International:企業の戦略・SWOT・財務情報
    Service Corporation International - Strategy, SWOT and Corporate Finance Report Summary Service Corporation International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Jouve SA:企業の戦略的SWOT分析
    Jouve SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Westfalen Weser Netz GmbH:企業の戦略的SWOT分析
    Westfalen Weser Netz GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • United Rentals, Inc.:企業のM&A・事業提携・投資動向
    United Rentals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Rentals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Infinera Corporation:戦略・SWOT・企業財務分析
    Infinera Corporation - Strategy, SWOT and Corporate Finance Report Summary Infinera Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Noxilizer Inc-医療機器分野:企業M&A・提携分析
    Summary Noxilizer Inc (Noxilizer) is a medical device company that manufactures sterilization equipment. The company’s products include industrial nitrogen dioxide sterilizer and biodecontamination systems. Its services comprise installation, contract sterilization services, and maintenance services …
  • University of Helsinki:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Helsinki (UOH) is an educational service provider that offers research and graduate programs. The university operates through independent institutes and faculties for theology, law, medicine, arts, science, pharmacy, biological and environmental sciences, behavioral sciences, s …
  • Torii Pharmaceutical Co Ltd (4551):製薬・医療:M&Aディール及び事業提携情報
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • inVentiv Health Inc-製薬・医療分野:企業M&A・提携分析
    Summary inVentiv Health Inc (inVentiv) is a Clinical Research Organization (CRO) and Contract Commercial Organization (CCO). The company offers a broad range of clinical development and commercialization services develop and marketing their products and services. Few of its service offerings include …
  • Oil States International, Inc. (OIS)-石油・ガス分野:企業M&A・提携分析
    Summary Oil States International, Inc. (Oil States) is an oilfield services company. It offers specialty products and services to oil and natural gas companies. The company’s product portfolio includes subsea equipment and offshore vessel, rig equipment, flexible bearings, connection systems, subsea …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Walmart Chile S.A.:企業の戦略的SWOT分析
    Walmart Chile S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆